Speaker illustration

Ms Frederique Suzanne Liljegren

Karolinska Institute, Stockholm (Sweden)

Progression and clinical manifestations in screening-detected atrial fibrillation: a five-year follow-up of the STROKESTOP study

Event: EHRA 2019

Topic: Stroke Prevention

Session: Atrial Fibrillation - Stroke Prevention

Thumbnail

ESC 365 is supported by

logo Novo Nordisk